Berlin, Germany

Monika Fischler


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Monika Fischler: Innovator in Catalytic Nucleic Acids

Introduction

Monika Fischler is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of active substance release systems through her innovative research and patents. Her work focuses on the development of temperature-dependent activation of catalytic nucleic acids, which has potential applications in various therapeutic areas.

Latest Patents

Monika Fischler holds 1 patent for her invention titled "Temperature dependent activation of catalytic nucleic acids for controlled active substance release." This invention relates to an active substance release system that includes two key compounds. The first compound consists of a nanoparticle combined with an oligonucleotide inhibition strand that is hybridized with a catalytically active nucleic acid. The second compound comprises a carrier that is combined with a substrate molecule linked to a therapeutic active substance. Through external stimulation, the catalytically active nucleic acid is released and binds specifically to the substrate molecule, leading to the cleavage of the substrate and the release of the active substance.

Career Highlights

Monika Fischler is associated with Magforce AG, where she continues to advance her research and development efforts. Her innovative approach to active substance release systems has positioned her as a key figure in her field.

Collaborations

Monika has collaborated with notable colleagues, including Jiang Gao and Volker A Erdmann, to further enhance her research initiatives and explore new avenues for innovation.

Conclusion

Monika Fischler's contributions to the field of catalytic nucleic acids and active substance release systems highlight her role as a leading inventor. Her innovative work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…